Angiotensin II receptor antagonists

Details for Australian Patent Application No. 2008330123 (hide)

Owner Merck Sharp & Dohme Corp. Nicox S.A.

Inventors Ali, Amjad; Ongini, Ennio; Lo, Michael Man-Chu; Biondi, Stefano; Storoni, Laura; Franklin, Chris; Stefanini, Silvia; Almirante, Nicoletta

Agent Spruson & Ferguson

Pub. Number AU-A-2008330123

PCT Pub. Number WO2009/070241

Priority 61/137,697 01.08.08 US; 61/004,320 26.11.07 US

Filing date 21 November 2008

Wipo publication date 4 June 2009

International Classifications

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/070241 Priority application(s): WO2009/070241

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.; Nicox S.A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008330125-Wise binding antibodies and epitopes

2008330122-Separation of nanostructures